Foren » Discussions » Test OG0-093 Dumps Pdf, OG0-093 Reliable Exam Cost

gywudosu
Avatar

2023 Latest Itbraindumps OG0-093 PDF Dumps and OG0-093 Exam Engine Free Share: https://drive.google.com/open?id=1dKg1z7TvAUF0k5jEu1CEYu9pHgXVZsuo I know you must want to get a higher salary, but your strength must match your ambition! The opportunity is for those who are prepared! OG0-093 exam questions can help you improve your strength! You will master the most practical knowledge in the shortest possible time. It is also very easy if you want to get the OG0-093 certificate. As long as you buy our OG0-093 study braindumps and practice step by step, you are bound to pass the exam.

How can you study for The Open Group OG0-093 Certification Exam

For The Open Group OG0-093 Certification Exam here is the study guide The Open Group OG0-093: Get our quick guide if you don't have time to read all the page OG0-093 TOGAF 9 is one of the most popular and highest-paid certifications in the industry. The Open Group OG0-093 TOFAF 9 is a certification focused on the fundamentals of IT that aims to promote practices. This certification is the best source of recognition for people who evaluate and control the understanding of ArchiMate specifications. In this guide, we will cover The Open Group OG0-093 Certification exam, The Open Group OG0-093 Certification Salary and all aspects of The Open Group OG0-093 Certification. >> Test OG0-093 Dumps Pdf <<

Fast Download Test OG0-093 Dumps Pdf & Correct The Open Group Certification Training - Marvelous The Open Group TOGAF 9 Combined Part 1 and Part 2

Itbraindumps provides The Open Group OG0-093 desktop-based practice software for you to test your knowledge and abilities. The OG0-093 desktop-based practice software has an easy-to-use interface. You will become accustomed to and familiar with the free demo for The Open Group OG0-093 Exam Questions. Exam self-evaluation techniques in our OG0-093 desktop-based software include randomized questions and timed tests. These tools assist you in assessing your ability and identifying areas for improvement to pass the TOGAF 9 Combined Part 1 and Part 2 exam.

Conclusion

OG0-093 is one of the most complex exams because it is a combination of both Part 1 and Part 2 certification tests. However, it is a great way to earn the TOGAF 9 Certified at once instead of taking the two parts separately. The test also helps the professionals to gain an upper hand in the industry by showing their expertise with the TOGAF framework.

The Open Group TOGAF 9 Combined Part 1 and Part 2 Sample Questions (Q245-Q250):

NEW QUESTION # 245
Which of the following best describes the Standards Information Base?

  • A. A repository area holding specifications to which architectures must conform
  • B. A repository area holding a description of the organization specific architecture framework and method
  • C. A repository area holding guidelines and templates used to create new architectures
  • D. A repository area holding processes to support governance of the Architecture Repository
  • E. A repository area holding a record of the governance activity across the enterprise

Answer: A
NEW QUESTION # 246
Scenario:
Please read this scenario prior to answering the Question
You are serving as the Lead Architect for an enterprise architecture project team within a leading medical device manufacturer that specializes in miniature devices. The latest product under development is a tiny wireless device that can be implanted in the brain and can deliver a precise electric shock when the wearable Pain Control Unit (PCU) detects an increase in stress induced by the onset of a migraine headache.
This technology will be a breakthrough in the treatment of this condition, and several competitors are striving to be the first to introduce a product into the market. However, all of them must demonstrate the effectiveness and safety of their products in a set of clinical trials that will satisfy the regulatory requirements of the countries in the target markets.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their independent clinical trials.
The Enterprise Architecture group is a mature organization that has been utilizing TOGAF for several years. They use the TOGAF 9 ADM with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant for each domain. A corresponding Security Architecture has been defined.
The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that the changes to the enterprise architecture for the new system will need to be rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials. The work will need to be done in stages and rolled out in geographical regions.
Refer to the Scenario
You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).
Based on TOGAF 9, which of the following is the best answer?

  • A. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new envelopment, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.
  • B. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time.
    Document the progression of the enterprise architecture using a state evolution table.
  • C. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.
  • D. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures.

Answer: A
NEW QUESTION # 247
Which of the following describes the TOGAF Technical Reference Model?

  • A. An Organization-Specific Architecture
  • B. A Common Systems Architecture
  • C. An Industry-Specific Architecture
  • D. A Foundation Architecture
  • E. A Solution Architecture

Answer: D
NEW QUESTION # 248
Which ADM phase includes establishing the Architecture Capability and definition of Architecture Principles?

  • A. Phase F: Migration Planning
  • B. Phase C: Data Architecture
  • C. Phase B: Business Architecture
  • D. Preliminary Phase
  • E. Phase A: Architecture Vision

Answer: D Explanation:
Section: Part 1
Explanation
Explanation/Reference: https://pubs.opengroup.org/architecture/togaf9-doc/arch/chap02.html
NEW QUESTION # 249
Scenario:
Please read this scenario prior to answering the Question
You are serving as the Lead Architect for an enterprise architecture project team within a leading medical device manufacturer that specializes in miniature devices. The latest product under development is a tiny wireless device that can be implanted in the brain and can deliver a precise electric shock when the wearable Pain Control Unit (PCU) detects an increase in stress induced by the onset of a migraine headache.
This technology will be a breakthrough in the treatment of this condition, and several competitors are striving to be the first to introduce a product into the market. However, all of them must demonstrate the effectiveness and safety of their products in a set of clinical trials that will satisfy the regulatory requirements of the countries in the target markets.
The Enterprise Architecture group within the company has been engaged in an architecture development project to create a secure networked collaboration system that will allow researchers at its product development laboratories worldwide to share information about their independent clinical trials.
The Enterprise Architecture group is a mature organization that has been utilizing TOGAF for several years. They use the TOGAF 9 ADM with extensions required to support current good manufacturing practices and good laboratory practices in their target markets. Due to the highly sensitive nature of the information that is managed, special care was taken to ensure that each architecture domain included an examination of the security and privacy issues that are relevant for each domain. A corresponding Security Architecture has been defined.
The Executive Vice President for Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that the changes to the enterprise architecture for the new system will need to be rolled out on a geographic basis that will minimize disruptions to ongoing clinical trials. The work will need to be done in stages and rolled out in geographical regions.
Refer to the Scenario
You have been asked to recommend the approach to identify the work packages that will be included in the Transition Architecture(s).
Based on TOGAF 9, which of the following is the best answer?

  • A. Use a Consolidated Gaps, Solutions and Dependencies Matrix as a planning tool. For each gap classify whether the solution is either a new envelopment, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture taking into account the schedule for clinical trials.
  • B. Determine the set of Solution Building Blocks required by identifying which Solution Building Blocks need to be developed and which need to be procured. Eliminate any duplicate building blocks. Group the remaining Solution Building Blocks together to create the work packages using a CRUD matrix. Rank the work packages in terms of cost and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.
  • C. Group the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture. Schedule the rollout one region at a time. Document the progression of the enterprise architecture using a state evolution table.
  • D. Create an Implementation Factor Assessment and Deduction Matrix and a Consolidated Gaps, Solutions and Dependencies Matrix. For each gap, identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar solutions together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the packages into a set of Capability Increments scheduled into a series of Transition Architectures.

Answer: A
NEW QUESTION # 250
...... OG0-093 Reliable Exam Cost: https://www.itbraindumps.com/OG0-093_exam.html P.S. Free 2023 The Open Group OG0-093 dumps are available on Google Drive shared by Itbraindumps: https://drive.google.com/open?id=1dKg1z7TvAUF0k5jEu1CEYu9pHgXVZsuo